There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Under this deal, Merck, known as MSD outside of the United States and Canada, will select Veeva products for industry-specific software and data.

Merck and Veeva Ink 10-Year Partnership Agreement

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Content is king in publishing, but interpretation is imperator.

Conference Time Brings Gifts

Meg Rivers is the former senior editor for 

Experts discuss factors that can affect the outcome of an ADME study, signs that a drug compound shows promise, red flags, and key parameters to determine safety and efficacy. 

ADME Studies: Determining Promising Drug Compounds 

Jennifer Markarian is a contributing editor for 

Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.

Considerations for E&L Analysis in Single-Use Systems

Klaus Lindpaintner, MD, MPH is chief scientific officer and distinguished scientist at InterVenn BioSciences.

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.

Using Novel Biomarkers to Facilitate AI-Driven Glycoproteomics

Feliza Mirasol is the science editor for 

An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.

Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk

OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.

OGT Launches New Panel and Workflow Solutions

Recent technological advancements may have put cleanroom monitoring into a state of flux.

Environmental Monitoring Advances

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Testing for Adventitious Agents in Viral Vector Production

Pramote Cholayudth previously was the managing director of the Professional Conference Center, Ltd. He currently is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM consult, cpramote2000@yahoo.com.

This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes